Exercise testing identifies high-risk silent ischaemia
This article was originally published in Clinica
A Finnish study has highlighted the importance of exercise testing as a means of predicting coronary heart disease (CHD) I asymptomatic, high-risk men. In men with increased risk of CHD, such as smokers and hypercholesterolaemic or hypertensive men, the identification of exercise-induced silent myocardial ischaemia is of significant additional prognostic value, researchers report in the Journal of the American College of Cardiology (July).
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.